Samlyn Capital »

Rapt Therapeutics shares owned by Samlyn Capital

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Samlyn Capital from 13F filings

Historical chart of Samlyn Capital investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by Samlyn Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by Samlyn Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $18M 712k 24.85
2023-03-31 $3.4M 186k 18.35

More positions owned by Samlyn Capital

First Solar Call Option (FSLR)
Lpl Financial Holdings (LPLA)
Natera Call Option (NTRA)
Voya Financial (VOYA)
Kenvue Call Option (KVUE)
Vanguard Index Fds Large Cap Etf (VV)
Core & Main Cl A (CNM)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Crocs (CROX)
Coca-cola Europacific Partne SHS (CCEP)
Take-Two Interactive Software (TTWO)
Merus N V (MRUS)
Planet Fitness Cl A (PLNT)

View all positions for Samlyn Capital

Top funds holding Rapt Therapeutics

T. Rowe Price Associates
Column Group
Perceptive Advisors
Vanguard Group
Dr. Jeffrey R. Jay, M.D.
Kingdon Capital Management
Samlyn Capital
Euclidean Capital
Alphabet
TimesSquare Capital Management
Cormorant Asset Management
Dimensional Fund Advisors
Millennium Management
Citadel Advisors
Braidwell

View all funds holding Rapt Therapeutics